Dysregulation of TET1 expression or function and aberrant methylation have been observed in a wide range of cancers, for example, gastric cancer, thyroid carcinoma, lung cancer, gliomas, esophageal carcinoma, and breast cancer [22–27]. This evidence concerns the gene TET1 and cancer.